🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the companies concealed safety concerns that the drug created to pediatric cognitive development.

The lawsuit arrives a month after President Donald Trump promoted an unsubstantiated connection between using acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "deceived the public by profiting off of pain and marketing drugs regardless of the potential hazards."

Kenvue asserts there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These corporations lied for decades, knowingly endangering millions to line their pockets," the attorney general, from the Republican party, stated.

Kenvue commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the welfare of American women and children."

On its online platform, Kenvue also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a verified association between consuming acetaminophen and autism."

Associations acting on behalf of doctors and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can create major wellness concerns if ignored.

"In over twenty years of research on the utilization of acetaminophen in gestation, no reliable research has conclusively proven that the usage of acetaminophen in any period of gestation results in neurological conditions in children," the group said.

The court filing references latest statements from the previous government in asserting the medication is allegedly unsafe.

Last month, Trump generated worry from medical authorities when he told expectant mothers to "struggle intensely" not to use Tylenol when ill.

Federal regulators then issued a notice that doctors should consider limiting the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism in children has not been proven.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to conduct "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a limited time.

But experts cautioned that finding a sole reason of autism - considered by experts to be the outcome of a complex mix of inherited and surrounding conditions - would not be simple.

Autism is a category of enduring cognitive variation and impairment that influences how individuals experience and interact with the surroundings, and is recognized using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking the Senate - asserts Kenvue and J&J "intentionally overlooked and tried to quiet the research" around acetaminophen and autism spectrum disorder.

The case aims to force the companies "remove any promotional materials" that asserts Tylenol is safe for expectant mothers.

The court case echoes the concerns of a group of mothers and fathers of children with autism and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in two years ago.

The court rejected the lawsuit, stating studies from the parents' expert witnesses was not conclusive.